Inova Health System, a not-for-profit healthcare system in Washington D.C., US, has renewed a system-wide pulse oximetry contract with Masimo.

As part of the renewed five-year contract, Inova Health System will install Masimo pulse oximetry technologies and devices at the Inova Loudoun Hospital.

The contract includes Masimo rainbow SET measurement capabilities, with Masimo’s handheld Rad-57 Pulse CO-Oximeter, which isdesigned to carry out swift noninvasive blood measurements.

"Inova Health System will install Masimo pulse oximetry technologies and devices at the Inova Loudoun Hospital."

The health system will deploy two new Masimo rainbow SET Pulse CO-Oximetry measurements – carboxyhemoglobin (SpCO) and methemoglobin (SpMet) – to measure carbon monoxide and methemoglobin blood levels respectively.

Masimo’s upgradable technology platform enables the system to improve its existing Radical-7 bedside monitors to include additional Masimo rainbow SET measurements.

Masimo technology features the greatest pulse oximetry specificity and sensitivity, in addition to noninvasive patient monitoring solutions, according to the company.

The technology aids in measuring multiple blood constituents, such as oxygen content (SpOC), SpCO, SpMet, acoustic respiration rate (RRa) and perfusion index (PI), as well as the Measure-Through Motion and Low Perfusion performance of Masimo SET oxyhemoglobin (SpO2) and pulse rates (PR).

Masimo claimed that the SET technology was designed to effectively monitor blood oxygen saturation in various independent clinical studies, thereby improving patient assessments and resulting in positive patient outcomes.